We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.36B
AUM Growth
-$1.68B
Cap. Flow
-$1.45B
Cap. Flow %
-43.28%
Top 10 Hldgs %
28.65%
Holding
6,080
New
399
Increased
1,937
Reduced
2,718
Closed
947

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$101M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$97.8M
4
MSFT icon
Microsoft
MSFT
+$89.5M
5
AMZN icon
Amazon
AMZN
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Financials 9.87%
3 Consumer Discretionary 8.34%
4 Healthcare 7.98%
5 Communication Services 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMRX icon
3751
Immuneering
IMRX
$327M
$9.62K ﹤0.01%
6,328
+3,928
+164% +$7.13K
GLSI icon
3752
Greenwich LifeSciences
GLSI
$247M
$9.61K ﹤0.01%
1,007
-41
-4% -$497
DDM icon
3753
ProShares Ultra Dow30
DDM
$542M
$9.61K ﹤0.01%
+210
New +$10.3K
DIBS icon
3754
1stdibs.com
DIBS
$165M
$9.58K ﹤0.01%
3,150
-696
-18% -$2.5K
DHIL
3755
DELISTED
Diamond Hill
DHIL
$9.57K ﹤0.01%
67
-358
-84% -$52.9K
TLRY icon
3756
Tilray
TLRY
$643M
$9.57K ﹤0.01%
1,455
-1,733
-54% -$16K
CTGO icon
3757
Contango Silver & Gold Inc
CTGO
$677M
$9.57K ﹤0.01%
937
+8
+0.9% +$82
OKUR
3758
OnKure Therapeutics
OKUR
$162M
$9.56K ﹤0.01%
2,224
+23
+1% +$129
OVLY icon
3759
Oak Valley Bancorp
OVLY
$287M
$9.56K ﹤0.01%
383
-1,123
-75% -$29.3K
QRHC icon
3760
Quest Resource Holding
QRHC
$33.7M
$9.55K ﹤0.01%
3,675
+1,550
+73% +$7.34K
NUTX
3761
Nutex Health
NUTX
$1.28B
$9.55K ﹤0.01%
+203
New +$9.9K
TSHA icon
3762
Taysha Gene Therapies
TSHA
$1.94B
$9.54K ﹤0.01%
6,864
-44,221
-87% -$74K
CRVS icon
3763
Corvus Pharmaceuticals
CRVS
$1.25B
$9.54K ﹤0.01%
2,999
-10,823
-78% -$51K
GOLY icon
3764
Strategy Shares Gold-Hedged Bond ETF
GOLY
$88.7M
$9.53K ﹤0.01%
+343
New +$8.87K
APLT
3765
DELISTED
Applied Therapeutics
APLT
$9.51K ﹤0.01%
19,455
-4,970
-20% -$2.93K
VEON icon
3766
VEON
VEON
$3.93B
$9.51K ﹤0.01%
218
+166
+319% +$7.38K
LVO icon
3767
LiveOne
LVO
$57.2M
$9.5K ﹤0.01%
1,359
+294
+28% +$2.9K
NOTE
3768
DELISTED
FiscalNote
NOTE
$9.5K ﹤0.01%
979
-66
-6% -$993
CTNM
3769
Contineum Therapeutics
CTNM
$534M
$9.48K ﹤0.01%
1,358
+415
+44% +$3.77K
GTE icon
3770
Gran Tierra Energy
GTE
$325M
$9.46K ﹤0.01%
1,919
-1,622
-46% -$9.31K
RMR icon
3771
The RMR Group
RMR
$346M
$9.46K ﹤0.01%
568
-388
-41% -$7.13K
HBT icon
3772
HBT Financial
HBT
$1.35B
$9.46K ﹤0.01%
422
-1,036
-71% -$24.4K
TUSK icon
3773
Mammoth Energy Services
TUSK
$160M
$9.46K ﹤0.01%
4,636
+995
+27% +$2.65K
TLK icon
3774
Telkom Indonesia
TLK
$14.6B
$9.45K ﹤0.01%
640
+578
+932% +$9.03K
AFCG
3775
AFC Gamma
AFCG
$72.1M
$9.45K ﹤0.01%
1,697
-481
-22% -$3.82K

Similar funds

Tower Research Capital (TRC)'s Q1 2025 Portfolio in Review

As of Q1 2025, Tower Research Capital (TRC) held 6,080 positions worth $3.36B, down 33% from $5.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.45B in Q1 2025, closing 947 positions and reducing 2,718 holdings. Its most notable exit was Listed Funds Trust Roundhill Magnificent Seven ETF, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $18.3M.

  • Tower Research Capital (TRC)'s largest Q1 2025 buy was Vanguard S&P 500 ETF: 35,404 shares worth $18.3M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2025, an estimated $274M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2025 reduction was Apple, cutting an estimated $126M.
  • Tower Research Capital (TRC) fully exited Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3.36B portfolio in Q1 2025.
  • Tower Research Capital (TRC) opened 399 new positions and closed 947 in Q1 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 33% quarter-over-quarter to $3.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.